Collectively, these findings posit that miR-760 exerts a restraining influence on glioma growth by orchestrating the upregulation of miR-760 along the miR-760/MMP2 axis. The delineation of the miR-760/MMP2 axis promises to broaden our comprehension of the intricate molecular mechanisms underpinning glioma proliferation and may unveil prospective therapeutic avenues for the management of glioma.
Both serum miR-760 and miR-601 may be used as potential biomarkers of NSCLC in Egyptian patients with a stronger staging and diagnostic potential for miR-760.
Both serum miR-760 and miR-601 may be used as biomarkers of NSCLC in Egyptian patients with a strong staging and diagnostic potential for miR-760. Keywords:MiR-601, miR-760, non-small cell lung cancer, prognosis, diagnosis